Shanghai Junshi Biosciences, a Chinese drug developer backed by Hillhouse Capital, is seeking to raise up to HK$3.2 billion ($414 million) through a Hong Kong IPO.
The company – which is listing under provisions that allow biotech companies to sell shares on the Hong Kong Stock Exchange despite having little or no revenue – is planning to sell 158.9 million shares...
Legend Capital sees Mancando's extensive network of brick-and-mortar outlets as the key to bringing greater supply chain efficiency to the Chinese auto parts industry
Advantage Partners has made its first acquisition in Vietnam, buying women’s fashion brand Elise Fashion for an undisclosed amount.
GIC Private has led a RMB850 million ($125.5 million) Series C round for Burning Rock, a Chinese cancer diagnostics start-up that is already working with hospitals on products based on DNA sequencing analysis.
Beacon Venture Capital, the VC unit of Thailand’s Kasikornbank, has led a $6.5 million investment in Jitta, a local financial technology provider and stock analysis platform operator.